Potential Patchwork Of Local Drug Take-Back Programs Poses Problem For OTC Firms
This article was originally published in The Tan Sheet
Executive Summary
CHPA backs litigation challenging drug take-back requirements to help stave off a patchwork of similar programs. Consumer education requires “a long-term commitment and won't be cheap,” but the OTC industry “can push back against more onerous mandates, says CHPA chief Scott Melville.
You may also be interested in...
CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates
OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.
CHPA Optimistic Voluntary Drug Takeback Efforts Will Stall Spread Of Mandates
OTC industry trade groups will more aggressively push for an education program to encourage proper disposal of Rx and OTC drugs as states consider mandating industry-funded takeback programs and a patchwork of local ordinances expands.
State Officials Urging Rx Pseudoephedrine Face Strong Lobby
Officials from Mississippi, Missouri, Oregon and South Carolina and the National Narcotics Officers Associations Coalition testifying before a House subcommittee call for moving all PSE products to prescription status.